IHS Chemical Week

World News and Views :: Top of the News

Wacker Biotech acquires biologics firm in Germany

8:40 AM MST | November 12, 2013 | Natasha Alperowicz

Wacker Biotech, a subsidiary of Wacker Chemie, today announced plans to acquire a production site for bioengineered pharmaceutical proteins (biologics), including the associated business, from BioNet Ventures. The two companies today signed the purchase agreement, which covers Wacker's acquisition of Scil Proteins Production, including the patent portfolio, at the Scil site at Halle, Germany. The transaction is expected to close early next year.   Wacker will continue with existing customer partnerships, which Scil Proteins Production already has, and will...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa